Study Finds 3 in 4 Overweight, Obese Adults Have Steatotic Liver Disease MASH

As much as 75% of overweight and obese individuals have steatotic liver disease, according to results of a recent cross-sectional, observational study.

FEBRUARY 11, 2025

Complex Interplay Between MASLD and Chronic HBV Infections

The prevalence of MASLD has increased worldwide and is particularly problematic among patients with chronic HBV, according to new research.

JANUARY 21, 2025

New Analyses Evaluate Resmetirom’s Effects on MASH and Fibrosis

Patients with MASH and F2 or F3 fibrosis treated with resmetirom had improvements in both fibrosis and MASH over 52 weeks of treatment.

JANUARY 13, 2025

Accelerated FDA Approval Ushers In New Era in Primary Biliary Cholangitis Treatment

The FDA’s recent accelerated approval of seladelpar for the treatment of PBC is a critical advancement for patients with PBC, experts say.

JANUARY 13, 2025

Study Assesses DILI Due to Medications For Alcohol Use Disorder

Medications for AUD generally are safe with respect to drug-induced liver injury, except for disulfiram, according to a new analysis.

JANUARY 10, 2025

Looking at Disease Course and Mortality in MASH Patients

A new study of patients with MASH shows a six-year mortality rate of 10% in patients with compensated cirrhosis.

JANUARY 9, 2025

Winter 2025 Issue

Priority Report: Hepatology Insights

The Digital Edition of the Winter 2025 issue.

JANUARY 8, 2025

Disappointing Results for U.S. Hepatitis C Clearance Cascade

Only 34% of people with diagnosed hepatitis C virus in the United States have achieved viral clearance, according to data from 2013 to 2022.

JANUARY 13, 2024

A Stepwise Approach to Patients With Abnormal Liver Enzymes

Abnormal liver tests are a common indication for referral to a gastroenterologist. This article outlines a stepwise, guideline-based approach to management of these patients.

JANUARY 3, 2024

First-Degree Relatives of MASLD Patients Are at Higher Risk for HCC

Some relatives of people with metabolic dysfunction–associated steatotic liver disease are at higher risk for developing hepatocellular carcinoma, according to a longitudinal study.

DECEMBER 24, 2023

Improved Biomarkers Can Aid HCC Diagnosis, Predict Disease Course

Researchers in the Netherlands and Latin America have identified a new score using existing serum biomarkers to detect early stages of hepatocellular carcinoma.

DECEMBER 23, 2023

Combination of Noninvasive Tests Identifies Later-Stage Fibrosis in MASH

A combination of noninvasive tests can identify patients with metabolic dysfunction–associated steatohepatitis who have stage F2 or F3 pre-cirrhotic fibrosis.

DECEMBER 22, 2023